Literature DB >> 23282876

Interactions between chronic liver disease and inflammatory bowel disease.

E V Loftus1, W J Sandborn, K D Lindor, N F Larusso.   

Abstract

Entities:  

Year:  1997        PMID： 23282876

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  14 in total

1.  PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis.

Authors:  E V Loftus; G C Harewood; C G Loftus; W J Tremaine; W S Harmsen; A R Zinsmeister; D A Jewell; W J Sandborn
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

Review 2.  Practical clinical approach to the evaluation of hepatobiliary disorders in inflammatory bowel disease.

Authors:  Afif Yaccob; Amir Mari
Journal:  Frontline Gastroenterol       Date:  2018-10-09

3.  Publisher Correction: The gut-liver axis and the intersection with the microbiome.

Authors:  Anupriya Tripathi; Justine Debelius; David A Brenner; Michael Karin; Rohit Loomba; Bernd Schnabl; Rob Knight
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-12       Impact factor: 46.802

Review 4.  Cancer surveillance in patients with primary sclerosing cholangitis.

Authors:  Nataliya Razumilava; Gregory J Gores; Keith D Lindor
Journal:  Hepatology       Date:  2011-11       Impact factor: 17.425

Review 5.  Hepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalk.

Authors:  Udayakumar Navaneethan
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-06-20

6.  Primary sclerosing cholangitis and the risk of colon neoplasia in patients with Crohn's colitis.

Authors:  Udayakumar Navaneethan; Tarun Rai; Preethi Gk Venkatesh; Ravi P Kiran
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-02-26

Review 7.  Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).

Authors:  Jochen Mattner
Journal:  Int J Mol Sci       Date:  2016-11-09       Impact factor: 5.923

8.  Liver test abnormalities predict complicated disease behaviour in patients with newly diagnosed Crohn's disease.

Authors:  Jessika Barendregt; Myrthe de Jong; Jeoffrey J Haans; Bart van Hoek; James Hardwick; Roeland Veenendaal; Andrea van der Meulen; Nidhi Srivastava; Rogier Stuyt; Jeroen Maljaars
Journal:  Int J Colorectal Dis       Date:  2016-11-29       Impact factor: 2.571

9.  Liver Function Test Abnormalities in Patients with Inflammatory Bowel Diseases: A Hospital-based Survey.

Authors:  Maria Cappello; Claudia Randazzo; Ivana Bravatà; Anna Licata; Sergio Peralta; Antonio Craxì; Piero Luigi Almasio
Journal:  Clin Med Insights Gastroenterol       Date:  2014-06-17

10.  Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single-arm, two-stage, open-label, multi-centre, phase II clinical trial protocol.

Authors:  Katherine Arndtz; Margaret Corrigan; Anna Rowe; Amanda Kirkham; Darren Barton; Richard P Fox; Laura Llewellyn; Amrita Athwal; Manpreet Wilkhu; Yung-Yi Chen; Chris Weston; Amisha Desai; David H Adams; Gideon M Hirschfield
Journal:  BMJ Open       Date:  2017-07-03       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.